BioMarin Pharmaceutical Cash Conversion Cycle 2011-2025 | BMRN

Annual Cash Conversion Cycle BioMarin Pharmaceutical

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
819	769	679	653	561	527	458	539	356	295	290	335	324	604

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
819	290	515

Quarterly Cash Conversion Cycle BioMarin Pharmaceutical

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
883	841	-	662	897	908	-	808	754	692	-	367	328	680	-	733	586	616	-	423	746	640	-	715	890	702	-	694	697	632	-	801	846	830	-	709	693	737	-	748	652	680	-	592	572	664	-	487	587	594	-	466	486	677	-	564	645	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
908	328	673

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Arbutus Biopharma Corporation ABUS	31.5	$ 4.93	4.78 %	$ 818 M	Canada
Aclaris Therapeutics ACRS	-881	$ 3.2	-1.69 %	$ 247 M	USA
Aptevo Therapeutics APVO	-47.4	$ 1.07	-5.75 %	$ 295 K	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	166	$ 26.45	4.67 %	$ 1.28 B	USA
Anika Therapeutics ANIK	270	$ 9.6	0.37 %	$ 141 M	USA
Catalyst Biosciences CBIO	391	$ 12.98	-7.91 %	$ 854 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Axon Enterprise AXON	86.2	$ 548.58	-2.78 %	$ 41.6 B	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	174	$ 2.37	2.83 %	$ 14.9 M	USA
AstraZeneca PLC AZN	-58	$ 91.59	1.95 %	$ 96.9 B	Britain
Celldex Therapeutics CLDX	-6.08 K	$ 27.09	-1.53 %	$ 1.74 M	USA
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	149	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Biohaven Pharmaceutical Holding Company Ltd. BHVN	209	$ 11.33	-1.78 %	$ 733 M	USA
Biogen BIIB	387	$ 175.2	0.63 %	$ 25.5 B	USA
Abeona Therapeutics ABEO	387	$ 5.07	-5.5 %	$ 108 M	USA
Corcept Therapeutics Incorporated CORT	-186	$ 87.67	-0.36 %	$ 9.05 B	USA
ADiTx Therapeutics ADTX	-4.31 K	$ 1.43	-36.18 %	$ 18.8 K	USA
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	214	-	-7.31 %	$ 87 M	USA
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Catalyst Pharmaceuticals CPRX	54.2	$ 24.29	2.84 %	$ 2.88 B	USA